- Home
- ZDGE vs PDSB Comparison
ZDGE vs PDSB Comparison
Compare ZDGE & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- PDSB
- Stock Information
- Founded
- ZDGE 2008
- PDSB 2005
- Country
- ZDGE United States
- PDSB United States
- Employees
- ZDGE N/A
- PDSB N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- ZDGE Technology
- PDSB Health Care
- Exchange
- ZDGE Nasdaq
- PDSB Nasdaq
- Market Cap
- ZDGE 42.3M
- PDSB 44.5M
- IPO Year
- ZDGE N/A
- PDSB N/A
- Fundamental
- Price
- ZDGE $2.86
- PDSB $0.89
- Analyst Decision
- ZDGE
- PDSB Strong Buy
- Analyst Count
- ZDGE 0
- PDSB 2
- Target Price
- ZDGE N/A
- PDSB $10.00
- AVG Volume (30 Days)
- ZDGE 103.5K
- PDSB 809.0K
- Earning Date
- ZDGE 12-15-2025
- PDSB 11-14-2025
- Dividend Yield
- ZDGE 2.25%
- PDSB N/A
- EPS Growth
- ZDGE N/A
- PDSB N/A
- EPS
- ZDGE N/A
- PDSB N/A
- Revenue
- ZDGE $29,398,000.00
- PDSB N/A
- Revenue This Year
- ZDGE $2.37
- PDSB N/A
- Revenue Next Year
- ZDGE $4.54
- PDSB N/A
- P/E Ratio
- ZDGE N/A
- PDSB N/A
- Revenue Growth
- ZDGE N/A
- PDSB N/A
- 52 Week Low
- ZDGE $1.73
- PDSB $0.85
- 52 Week High
- ZDGE $4.89
- PDSB $3.41
- Technical
- Relative Strength Index (RSI)
- ZDGE 46.32
- PDSB 41.12
- Support Level
- ZDGE $2.21
- PDSB $0.87
- Resistance Level
- ZDGE $3.85
- PDSB $0.96
- Average True Range (ATR)
- ZDGE 0.30
- PDSB 0.07
- MACD
- ZDGE -0.05
- PDSB 0.00
- Stochastic Oscillator
- ZDGE 39.66
- PDSB 14.75
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.